AAL
24
-2
AVGO
49
9
CINF
53
-3
ADT
66
-2
AME
51
-3
DG
36
-23
CFG
56
-4
DE
50
-18
DGX
44
-20
EQIX
58
-11
DHR
50
-20
EMR
48
-25
EL
30
-18
DOV
61
-14
DIS
69
-13
CMG
44
-30
CLX
56
-20
COST
35
-28
EMC
45
-47
ADI
49
-2
AAL
24
-2
AVGO
49
9
CINF
53
-3
ADT
66
-2
AME
51
-3
DG
36
-23
CFG
56
-4
DE
50
-18
DGX
44
-20
EQIX
58
-11
DHR
50
-20
EMR
48
-25
EL
30
-18
DOV
61
-14
DIS
69
-13
CMG
44
-30
CLX
56
-20
COST
35
-28
EMC
45
-47
ADI
49
-2
Financhill
Back

Evolus Stock Predictions

Why Private Investors Didn't Lose a Penny in the Market's Recent $1T Crash

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
28

EOLS
Evolus

Last Price:
$13.29
Seasonality Move:
12.33%

7 Day Trial

ALL ACCESS PASS

$ 7

Meet the Founder that's Revolutionizing Smartphones

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.

Evolus Stock Forecast

  • Over the next 52 weeks, Evolus has on average historically risen by 47.3% based on the past 7 years of stock performance.
  • Evolus has risen higher in 3 of those 7 years over the subsequent 52-week period, corresponding to a historical accuracy of 42.86%
  • Is Evolus Stock Undervalued?
    The current Evolus [EOLS] share price is $13.25. The Score for EOLS is 28, which is 44% below its historic median score of 50, and infers higher risk than normal.
  • EOLS is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.

Will Evolus Stock Go Up Next Year?

  • Over the next 52 weeks, Evolus has on average historically risen by 47.3% based on the past 7 years of stock performance.

Evolus Stock Rating

Sell
28
Evolus (EOLS) is a Sell

Is Evolus overpriced?

  • Evolus has risen higher in 3 of those 7 years over the subsequent 52-week period, corresponding to a historical accuracy of 42.86%

Evolus Stock Price History

Is EOLS stock going to rise?

  • Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and EOLS is experiencing slight selling pressure.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Pharmaceuticals
Sector:
Health Care
Type:
stock
Website:
evolus.com

52-Week Data

52-Week High:
17.82
52-Week Low:
9.25

Prediction Charts

Market Cap:
842.5M
Price in USD:
13.25
Volume:
663.4K
Beta:
1.86

Technical Analysis

SMA50:
13.19
SMA100:
13.19
SMA200:
13.52
52-Wk Change:
-5.02%

Stock Predictions

  • Is Evolus stock public?
    Yes, Evolus is a publicly traded company.
  • What is the Evolus stock quote today?
    The Evolus stock price is 13.25 USD today.
  • How to buy Evolus stock online?
    You can buy Evolus shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Feb-28 13.91 14.59 14.61 13.75
Mar-3 14.66 14.34 14.94 14.10
Mar-4 14.10 14.33 14.43 13.85
Mar-5 14.50 14.17 14.60 13.47
Mar-6 13.73 13.50 14.28 13.38
Mar-7 13.45 13.58 13.81 13.24
Mar-11 12.60 12.71 12.86 12.04
Mar-12 12.74 13.42 13.43 12.66
Mar-13 13.27 12.96 13.41 12.71
Mar-14 13.10 13.20 13.22 12.75
Mar-17 13.24 13.59 13.59 13.10
Mar-18 13.38 13.28 13.48 13.07
Mar-19 13.28 13.47 13.65 13.10
Mar-20 13.32 13.25 13.66 13.03

Evolus Earnings

Evolus Earnings Report: Per Share Evolus Earnings Q1 Q2 Q3 and Q4 last year and next year.

Evolus Forecast Revenue Growth

Evolus Stock Analysis: Historical quarterly revenues per share for Evolus and historical quarterly revenue growth:

  • Analysts estimate an earnings increase this quarter of $0.09 per share, an increase next quarter of $0.14 per share, an increase this year of $0.26 per share, and an increase next year of $0.70 per share.

* Evolus stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.